Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients

Androgen deprivation therapy (ADT) is the standard of care for patients with metastatic prostate cancer. However, whether serum testosterone levels, using a cut-off point of 50 ng dl(−1), are related to the effective time of ADT in newly diagnosed prostate cancer patients remains controversial. More...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yue, Dai, Bo, Ye, Ding-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312215/
https://www.ncbi.nlm.nih.gov/pubmed/26975487
http://dx.doi.org/10.4103/1008-682X.174856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312215/
https://www.ncbi.nlm.nih.gov/pubmed/26975487
http://dx.doi.org/10.4103/1008-682X.174856

Ejemplares similares